• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,400.82 769.17
( 1.00%)
Global Indices
Nasdaq
48,208.69 277.76
(0.58%)
Dow Jones
6,845.97 42.16
(0.62%)
Hang Seng
56,916.27 1,020.95
(1.83%)
Nikkei 225
10,579.52 -29.36
(-0.28%)
Forex
USD-INR
92.44 -0.46
(-0.50%)
EUR-INR
107.96 0.52
(0.48%)
GBP-INR
124.05 0.88
(0.72%)
JPY-INR
0.58 0.00
(0.32%)

EQUITY - MARKET SCREENER

Classic Electricals Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
512213
INE02BR01017
61.8544174
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
2.53
0.52
EPS(TTM)
Face Value()
Div & Yield %
1.07
10
0
 

aditya birla sun life crisil liquid overnight etf
Aurobindo Pharma receives USFDA approval for Dapagliflozin and Metformin Hydrochloride XR Tablets
Apr 07,2026
Aurobindo Pharma announced that the final approval is received from the US Food & Drug Administration (USFDA) to manufacture and market Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets, 5 mg/ 500 mg, 5 mg/1000 mg, 10 mg/500 mg, and 10 mg/1000 mg, which is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Xigduo XR Tablets, 5 mg/ 500 mg, 5 mg/1000 mg, 10 mg/500 mg, and 10 mg/1000 mg, of AstraZeneca AB. These products will be manufactured at Unit-IV of APL Healthcare, a wholly owned subsidiary of the Company and will be launched immediately.